United Therapeutics reported $4.36 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023.

Fiscal Calendar Actual Consensus Previous Date
FY2024Q1 Mar/2024 5.79 4.86 May/01 2024
FY2023Q4 Dec/2023 4.36 4.44 2.67 Feb/21 2024
FY2023Q3 Sep/2023 5.38 5.15 4.91 Nov/01 2023
FY2023Q2 Jun/2023 5.24 4.49 2.41 Aug/02 2023
FY2023Q1 Mar/2023 4.86 4.41 5.03 May/03 2023
FY2022Q4 Dec/2022 2.67 4.54 2.35 Feb/22 2023
FY2022Q3 Sep/2022 4.91 4.00 3.42 Nov/02 2022
FY2022Q2 Jun/2022 2.41 4.02 3.65 Aug/03 2022
FY2022Q1 Mar/2022 5.03 3.30 0.61 May/04 2022
FY2021Q4 Dec/2021 2.35 3.68 2.19 Feb/24 2022
FY2021Q3 Sep/2021 3.42 3.58 3.86 Nov/03 2021
FY2021Q2 Jun/2021 3.65 3.01 2.41 Aug/04 2021

Eps Change Date
Amarin USD -0.01 0.03 Dec/2023
Ardelyx USD -0.12 0.15 Dec/2023
Baxter International USD 0.88 0.2 Dec/2023
Bayer EUR 1.85 1.47 Dec/2023
Biogen USD 3.67 0.37 Mar/2024
BioMarin Pharmaceutical USD 0.71 0.53 Mar/2024
Gilead Sciences USD 1.72 0.57 Dec/2023
GlaxoSmithKline GBP 0.29 0.22 Dec/2023
Halozyme Therapeutics USD 0.82 0.07 Dec/2023
Insmed USD -1.28 0.17 Dec/2023
Intra Cellular Therapies USD -0.3 0.05 Dec/2023
Ionis Pharmaceuticals USD -0.06 0.97 Dec/2023
J&J USD 2.71 0.42 Mar/2024
Moderna USD 0.55 10.08 Dec/2023
Pfizer USD 0.1 0.27 Dec/2023
PTC Therapeutics USD -1.2 0.96 Mar/2024
Regeneron Pharmaceuticals USD 11.86 0.27 Dec/2023
Sarepta Therapeutics USD 0.47 0.93 Dec/2023
Teva Pharmaceutical Industries USD 1 0.4 Dec/2023
United Therapeutics USD 4.36 1.02 Dec/2023
Vertex Pharmaceuticals USD 4.2 0.12 Dec/2023